Pierre-Alain Ruffieux is a Chemical Engineer by training with a MSc and PhD from the Swiss Institute of Technology in Lausanne.
He is currently Lonza's Chief Executive Officer (CEO) and Member of the Executive Committee (since November 2020).
With more than 20 years of experience in technical development, manufacturing and quality, Pierre-Alain is an engaging leader with a proven track record of success, and a strong passion in people and team development.
Former Activities and Functions
Head of Global Pharma Technical Operations & Member Pharma Executive Team, F. Hoffmann-La Roche (2017–2020)
Head of Quality and Compliance, Global Pharma Technical Operations, F. Hoffmann-La Roche (2015–2017)
Head of Quality, Pharmaceutical Division & Member Pharmaceutical Executive Committee, Novartis Pharmaceuticals (2012–2015)
Head of Global Pharma Technical Operations & Biologics Quality Assurance, Novartis Pharmaceuticals (2010–2012)
Global Head of Quality for Biopharmaceutical, Novartis Pharmaceuticals (2009–2010)
Various positions in technical development and manufacturing at Novartis Pharmaceuticals & Sandoz, Novartis Group (2003–2009)
Various positions in technical development and manufacturing at Serono (now Merck Serono) (1998–2003)